Sign up to save your podcasts
Or
Share The obesity drug craze is entering its next phase
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The obesity drug craze is entering its next phase
Eli Lilly and Novo Nordisk can’t keep up with demand for their weight loss medications. In this Viewsroom podcast, Breakingviews columnists discuss the hype among celebrities, the different approaches to prescribing them in the US and Europe, and how they can reshape the world. Visit the Thomson Reuters Privacy Statement for information on our privacy and data protection practices. You may also visit megaphone.fm/adchoices to opt-out of targeted advertising.
Learn more about your ad choices. Visit megaphone.fm/adchoices
View all episodes
By Reuters
4.2
4444 ratings
Eli Lilly and Novo Nordisk can’t keep up with demand for their weight loss medications. In this Viewsroom podcast, Breakingviews columnists discuss the hype among celebrities, the different approaches to prescribing them in the US and Europe, and how they can reshape the world. Visit the Thomson Reuters Privacy Statement for information on our privacy and data protection practices. You may also visit megaphone.fm/adchoices to opt-out of targeted advertising.
Learn more about your ad choices. Visit megaphone.fm/adchoices
More shows like Viewsroom
View all
WSJ Tech News Briefing
1,643 Listeners
Economist Podcasts
4,208 Listeners
WSJ What’s News
4,322 Listeners
Bloomberg Businessweek
443 Listeners
Trumponomics
347 Listeners
The Big View
29 Listeners
WSJ Minute Briefing
661 Listeners
The Intelligence from The Economist
2,530 Listeners
The Journal.
5,955 Listeners
The World in Brief from The Economist
1,069 Listeners
AP Newswatch: Top Stories from the Associated Press
47 Listeners
The Big Take
157 Listeners
World in 10
78 Listeners
Reuters World News
242 Listeners
Reuters Econ World
27 Listeners